IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.091
-0.009 (-0.85%)
At close: Sep 11, 2026, 4:00 PM EDT
1.070
-0.021 (-1.89%)
After-hours: Sep 11, 2026, 6:02 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $10.75 million as of September 11, 2026. Its market cap has increased by 24.00% in one year.
Market Cap
10.75M
Enterprise Value
-5.03M
1-Year Change
24.00%
Ranking
Category
Stock Price
$1.09
ChartMarket Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $10.75M, a decrease of -94.27%. That is a compound annual growth rate of -42.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 10.75M | -52.93% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 11.53M |
| FibroBiologics | 11.52M |
| Kiora Pharmaceuticals | 11.41M |
| BioLineRx | 11.20M |
| GT Biopharma | 11.15M |
| Theriva Biologics | 11.14M |
| Lunai Bioworks | 11.04M |
| Azitra | 10.91M |